MCAC Referral Draft Guidelines Need Clarity, More Specificity – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
Guidelines specifying how the public can best frame evidentiary questions used in MCAC review should be included in a 1CMS draft guidance stipulating criteria for when an NCD should be referred to the committee, AdvaMed maintains
You may also be interested in...
Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period
Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee
MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool
Guidant's subgroup analysis demonstrating that non-inducible EP-tested patients showed lower mortality rates with ICDs over conventional therapy played a decisive factor in MCAC's endorsement of national coverage
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.